Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,438 | 4 | 47.4% |
| Food and Beverage | $4,124 | 94 | 44.1% |
| Gift | $792.00 | 4 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $3,781 | 7 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $1,693 | 30 | $0 (2024) |
| Allergan, Inc. | $1,281 | 25 | $0 (2022) |
| Saol Therapeutics Inc. | $866.73 | 5 | $0 (2022) |
| ABBVIE INC. | $645.56 | 16 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $639.47 | 14 | $0 (2020) |
| Pacira Pharmaceuticals Incorporated | $283.15 | 4 | $0 (2024) |
| Abbott Laboratories | $163.89 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,451 | 28 | Merz Pharmaceuticals, LLC ($619.34) |
| 2023 | $818.28 | 20 | Merz Pharmaceuticals, LLC ($640.02) |
| 2022 | $492.42 | 10 | Merz Pharmaceuticals, LLC ($284.69) |
| 2021 | $3,954 | 9 | Ipsen Biopharmaceuticals, Inc ($3,650) |
| 2020 | $449.75 | 7 | MERZ NORTH AMERICA, INC. ($319.61) |
| 2019 | $1,012 | 10 | Saol Therapeutics Inc. ($660.00) |
| 2018 | $207.97 | 7 | Merz North America, Inc. ($108.81) |
| 2017 | $967.04 | 11 | Allergan Inc. ($803.15) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Musculoskeletal | ||||||
| 11/26/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: Musculoskeletal | ||||||
| 11/06/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Pain Management | ||||||
| 10/29/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $103.89 | General |
| Category: Musculoskeletal | ||||||
| 09/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: Musculoskeletal | ||||||
| 09/19/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: Musculoskeletal | ||||||
| 08/22/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Musculoskeletal | ||||||
| 08/13/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $87.40 | General |
| Category: Musculoskeletal | ||||||
| 07/16/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Musculoskeletal | ||||||
| 07/15/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| 07/13/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $40.96 | General |
| Category: Pain Management | ||||||
| 07/11/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Neurology | ||||||
| 06/21/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Neurology | ||||||
| 06/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/30/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $45.11 | General |
| Category: Pain Management | ||||||
| 03/16/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $42.91 | General |
| Category: Musculoskeletal | ||||||
| 03/14/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Neurology | ||||||
| 03/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/01/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $172.24 | General |
| Category: Musculoskeletal | ||||||
| 02/23/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $82.10 | General |
| Category: Musculoskeletal | ||||||
| 02/21/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $72.96 | General |
| Category: Pain Management | ||||||
| 02/08/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 426 | 21,379 | $710,059 | $178,471 |
| 2022 | 13 | 423 | 23,535 | $749,977 | $181,412 |
| 2021 | 13 | 424 | 18,428 | $641,037 | $155,814 |
| 2020 | 12 | 339 | 13,328 | $426,974 | $111,729 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 20,400 | $326,400 | $101,411 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 463 | $138,620 | $33,362 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 81 | $34,830 | $8,349 | 24.0% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 16 | 35 | $24,150 | $5,828 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 71 | $20,590 | $5,201 | 25.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 51 | 101 | $16,160 | $4,726 | 29.2% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 17 | 40 | $16,000 | $3,582 | 22.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 29 | 63 | $49,684 | $3,444 | 6.9% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 14 | 25 | $40,975 | $2,978 | 7.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $14,400 | $2,675 | 18.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 31 | 31 | $8,990 | $2,364 | 26.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 18 | $9,720 | $2,145 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $6,300 | $1,548 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 18 | $3,240 | $857.10 | 26.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 25 | 22,575 | $361,200 | $107,171 | 29.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 425 | $127,500 | $28,797 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 105 | $45,010 | $11,206 | 24.9% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 19 | 32 | $22,080 | $5,230 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 71 | $20,590 | $5,223 | 25.4% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 17 | 31 | $50,809 | $4,541 | 8.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 45 | 102 | $16,320 | $3,739 | 22.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 33 | 75 | $56,068 | $3,651 | 6.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 18 | $14,400 | $3,280 | 22.8% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 21 | 33 | $13,200 | $3,092 | 23.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 22 | $11,880 | $2,762 | 23.2% |
About Miguel Escalon, M.D., MPH
Miguel Escalon, M.D., MPH is a Physical Medicine & Rehabilitation healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1124256466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Miguel Escalon, M.D., MPH has received a total of $9,354 in payments from pharmaceutical and medical device companies, with $1,451 received in 2024. These payments were reported across 102 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($4,438).
As a Medicare-enrolled provider, Escalon has provided services to 1,612 Medicare beneficiaries, totaling 76,670 services with total Medicare billing of $627,426. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Spinal Cord Injury Medicine
- Location New York, NY
- Active Since 06/25/2009
- Last Updated 10/01/2014
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1124256466
Products in Payments
- DYSPORT (Drug) $3,650
- Xeomin (Biological) $1,693
- BOTOX (Biological) $1,180
- Lioresal (baclofen) (Drug) $660.00
- XEOMIN (Biological) $639.47
- BOTOX NEURO REHAB (Drug) $294.53
- Iovera (Device) $210.19
- DRG leads (Device) $163.89
- LIORESAL (BACLOFEN) (Drug) $132.00
- BOTOX (Drug) $131.56
- Dysport (Drug) $130.73
- Lioresal Intrathecal (baclofen injection) (Drug) $74.73
- Exparel (Drug) $72.96
- BOTOX THERAPEUTIC (Biological) $33.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in New York
Heidi Fusco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $160,307
Dr. Kimberly Sackheim, Do, DO
Physical Medicine & Rehabilitation — Payments: $158,974
Michael O'dell, Md, MD
Physical Medicine & Rehabilitation — Payments: $103,549
Dr. Craig Antell, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $78,788
Russell Silver, Md, MD
Physical Medicine & Rehabilitation — Payments: $66,937
Ehsan Abdeshahian, Md, MD
Physical Medicine & Rehabilitation — Payments: $54,837